Cytek Biosciences (CTKB) Free Cash Flow (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Free Cash Flow came in at -$4.9 million in Q1 2026, down 1266.02% YoY from $420577.2 in Q1 2025, and down 324.64% on a QoQ basis from $2.2 million in Q4 2025.
Cytek Biosciences (CTKB) Free Cash Flow (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Free Cash Flow data on file, last reported at -$4.9 million in Q1 2026.
- Quarterly Free Cash Flow fell 1266.02% year-over-year to -$4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.4 million (down 143.63% YoY) and the FY2025 annual result came in at -$4.8 million, down 119.11% from the prior year.
- Free Cash Flow retreated to -$4.9 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $14.7 million in Q3 2024 to a low of -$11.3 million in Q2 2022.
- A 5-year average of -$73823.5 and a median of -$337000.0 in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow jumped 3844.81% — and 2026, when it plunged 1266.02%.
- Tracing CTKB's Free Cash Flow over 5 years: stood at -$337000.0 in 2022, then jumped by 3844.81% to $12.6 million in 2023, then sank by 84.79% to $1.9 million in 2024, then advanced by 13.76% to $2.2 million in 2025, then slumped by 324.64% to -$4.9 million in 2026.
- The last three Free Cash Flow figures came in at -$4.9 million (Q1 2026), $2.2 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | -849,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -849,000.00 |
| Jun 30, 2026 | -849,000.00 |
| Mar 31, 2026 | -4.90 Mn |
| Mar 31, 2026 | -4.90 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Sep 30, 2025 | -6.94 Mn |
| Sep 30, 2025 | -6.94 Mn |
| Jun 30, 2025 | 302,000.00 |
| Jun 30, 2025 | 302,000.00 |
| Mar 31, 2025 | -359,000.00 |
| Mar 31, 2025 | -359,000.00 |
| Dec 31, 2024 | 1.92 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 14.74 Mn |
| Sep 30, 2024 | 14.74 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 3.39 Mn |
| Mar 31, 2024 | 3.39 Mn |